Submitted by Anonymous (not verified) on 17 February 2026 - 17:00
Human medicines European public assessment report (EPAR): Vevzuo, denosumab, Date of authorisation: 25/06/2025, Revision: 2, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Vevzuo, denosumab, Date of authorisation: 25/06/2025, Revision: 2, Status: Authorised